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Clinical Electrophysiology-A Decade of Progress
PABLO DENES. MD, FACC, MARILYN D. EZRI, MD
Chicago. Illinois
During the past 14 years there have been major advances
in the field of clinical electrophysiology. This progress
is a result of a more extensive use of intracardiac elec-
trode catheters with recordings from multiple sites in
the right and left cardiac chambers, the introduction of
programmed electrical stimulation techniques and the
use of antiarrhythmic drugs for diagnostic and thera-
peutic purposes during acute electrophysiologic testing.
This article examines the pioneering studies and the
subsequent developments in the field of clinical electro-
The standard electrocardiogram records the electrical activ-
ity of the heart from the body surface, and interpretation of
cardiac arrhythmias is based on the analysis of the config-
uration and relation of P waves and QRS complexes. The
development of intracardiac electrophysiologic recordings
and pacing techniques in the past decade has led to a better
understanding of the mechanisms and management of
arrhythmias.
Alanis. Gonzalez and Lopez (I) in 1958 were the first
to record the His bundle electrogram in the isolated canine
heart. In 1969, Scherlag et a1. (2) described the technique
for recording the His bundle electrogram in human beings.
The method consists of passing catheter electrodes into the
right heart chambers across the tricuspid valve. With ap-
propriate amplification and frequency filtering of the elec-
trical signal, the His bundle potential can be reliably recorded.
During the past 14 years major advances have been made
in the field of clinical electrophysiology. These advances
include: I) evaluation of sinus node function and the atrio-
ventricular (AV) conduction system with demonstration of
the presence of latent conduction disease; 2) replication of
supraventricular and ventricular arrhythmias in the cathe-
terization laboratory with evaluation of pharmacologic re-
sponses and antitachycardia pacing therapy; 3) development
of cardiac mapping techniques in the catheterization labo-
ratory and the operating room; and 4) development of an
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physiology. The specific topics that are reviewed include
the sinus node and atrium, atrioventricular conduction,
supraventricular tachycardia and ventricular tachycar-
dia. The therapeutic implications of each topic are also
discussed. Clinical electrophysiology in its initial stages
was a descriptive technique, but has since become an
important diagnostic and therapeutic tool. However.
electrophysiologic testing is an intensive process, re-
quiring specialized training and a substantial commit-
ment of human and physical resources.
entirely new field, antiarrhythmic surgery. This progress
has been a result of several factors including a more ag-
gressive use of intracardiac electrode catheters with record-
ings from multiple sites in all cardiac chambers and the
coronary sinus, the introduction of programmed electrical
stimulation techniques and the administration of antiar-
rhythmic drugs during electrophysiologic studies for diag-
nostic and therapeutic purposes.
In this article we review the advances that we believe
have made major contributions to the development of the
field of clinical electrophysiology. Because of space re-
straints we cannot include the important contributions of
basic electrophysiology. Also, because we have been active
participants in this field, some bias in our review is inevitable.
Sinus Node and Atrium
Sinus node function. The study of sinus node function
with electrophysiologic techniques in human subjects has
captivated the attention of many clinical investigators. In
1971, Rosen et a1. (3) and Mandel et al. (4) reported on the
use of overdrive suppression of the sinus node with atrial
pacing. The measurement of the pause after sudden ces-
sation of rapid atrial pacing (sinus node recovery time) was
used as an index of sinus node function. The sinus node
recovery time can be corrected for the sinus cycle (corrected
sinus node recovery time) (5), The measurement of sino-
atrial conduction time has also been used to evaluate sinus
node function in human subjects. In 1973 Strauss et a1. (6)
reported on a method for indirect calculation of sinoatrial
conduction time. In this method, single premature atrial
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stimuli are delivered and the timing of the return responses,
after reset of the sinus node, is measured. More recently,
the analysis of secondary pauses after the termination of
rapid pacing was added to the tests used to evaluate sinus
node function in patients (7). Some patients with sinus node
dysfunction demonstrate a marked slowing of the sinus node
discharge rate that is most noticeable several cycles after
atrial pacing is stopped. Direct recording of the sinus node
electrogram in human subjects has also been reported (8).
The ability to record these signals depends on proper po-
sitioning of the recording catheter and the high amplification
and appropriate filtering of the electrogram.
There is good correlation between the sinoatrial con-
duction time estimated by the atrial premature stimulus tech-
nique and the directly measured conduction time (8). Phar-
macologic denervation of the sinus node has also been used
to test sinus node function. Complete autonomic blockade
of the sinus node can be achieved by utilizing the protocol
of Jose and Collison (9). The resultant sinus rate is the
intrinsic heart rate. Patients with abnormal sinus function
due to intrinsic dysfunction of sinus node automaticity can
be distinguished from patients with autonomic dysfunction
of the regulation of sinus node activity (10).
Atrial conduction and arrhythmias. The clinical elec-
trophysiologic study of atrial arrhythmias has resulted in a
better understanding of the mechanism of atrial rhythm dis-
turbances. In 1973, Zipes and Dejoseph (II) demonstrated
dissimilar atrial rhythms in human subjects. By using mul-
tiple intracavitary recordings, they showed the presence of
dissimilar atrial rhythms with fibrillation in one atrium and
a slower more regular activity in the other atrium. The
limitations of the surface electrocardiogram in the diagnosis
of atrial arrhythmias were further emphasized by Wu et al.
(12). They described a patient whose surface electrocar-
diogram indicated atrial tachycardia with block whereas the
electrophysiologic studies showed right atrial standstill and
two dissimilar rhythms in the left atrium. Josephson et al.
(13) evaluated the electrocardiographic criteria for atrial
enlargement by using catheter mapping of both atria. They
demonstrated that electrocardiographic atrial enlargement
reflected delayed interatrial conduction and did not correlate
well with echocardiographic atrial enlargement.
The mechanism of atrial flutter has also been studied.
using electrophysiologic techniques. Intra- and interatrial
conduction delay has been demonstrated in patients with
atrial flutter (14). Atrial flutter can be initiated and termi-
nated with atrial stimulation (15,16). Waldo et al. (17) showed
that atrial flutter can also be entrained and interrupted with
atrial pacing. All these observations suggest that the mech-
anism of atrial flutter is reentry. With use of the single atrial
extrastimulus technique, closely coupled premature atrial
impulses may provoke one or more repetitive impulses (atrial
vulnerability) (18). The atrial vulnerability zone increases
as the driven cycle length is reduced. Atrial fibrillation can
also be induced with atrial pacing (19). Rapid atrial stim-
ulation can initiate atrial fibrillation in patients with preex-
citation with or without a previous history of atrial fibril-
lation (20). Bauernfeind et al. (21) recently showed that in
patients with a history of paroxysmal atrial fibrillation, the
arrhythmia can also be induced with single atrial extrastimuli.
Therapeutic Implications
"Sick sinus node syndrome" is a major cause of morbidity
in elderly persons and is probably the most common reason
for instituting permanent pacing. Although electrophysio-
logic studies of sinus node function have been extensively
performed in the normal and disease states, their clinical
usefulness in defining the indication for permanent pacing
remains controversial. Atrial pacing studies are only com-
plementary to the information obtained from clinical pre-
sentation, symptomatology, electrocardiographically doc-
umented arrhythmias, exercise testing and pharmacologic
testing (atropine or isoproterenol hydrochloride) when the
decision to use permanent pacing is made.
Electrophysiologic studies have been more helpful in the
management of atrial tachyarrhythmias. Pacing-induced
conversion of atrial flutter has been useful in managing
patients when electrical cardioversion is contraindicated (22).
A patient-triggered radiofrequency atrial pacemaker has been
used in the long-term management of recurrent atrial flutter
(23). Atrial pacing has been most helpful in the management
of atrial tachyarrhythmias after open heart surgery (24).
Chronic electrophysiologic studies in patients with parox-
ysmal atrial fibrillation have also proved helpful in defining
effective antiarrhythmic drug therapy for atrial fibrillation
(21). Successful surgical excision of focal paroxysmal atrial
tachycardia, based on endocardial and epicardial atrial map-
ping, has recently been reported in patients (25).
Atrioventricular Conduction
Patterns of atrioventricular conduction. The patterns
of atrioventricular conduction were described by Wit et al.
(26) in 1970. The responses to atrial extrastimuli were rep-
resented by plotting the A I-A2 atrial coupling interval against
the H I-H2 or VI-V2 responses. Similarly, the A I-A2 atrial
coupling intervals can be plotted against the ArH2 and Hr
V2 conduction times. Four different types of AV conduction
curves were described based on the varying sites of con-
duction delay and block within the AV conduction system.
Description of the normal AV conduction patterns aided in
the recognition of abnormal patterns of conduction, such as
conduction in the presence of dual AV nodal pathways or
enhanced AV nodal conduction. The occurrence of "su-
pernormal conduction," that is, the propagation of closely
coupled premature impulses, when premature beats with
longer coupling intervals are blocked, has intrigued the clin-
ical electrophysiologist. Early in the development of His
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bundle recording techniques, Gallagher et al. (27) and Agha
et al. (28) provided an explanation for the occurrence of
some cases of supernormal conduction in human beings.
This has been defined as the "gap phenomenon." Two
conditions are necessary for the appearance of this phenom-
enon: I) the occurrence of block in a distal site, and 2) a
proximal site of slowing that allows enough delay between
closely coupled impulses to ensure that the effective re-
fractory period of the distal site is exceeded and conduction
may be resumed (29).
Atrioventricular blocks. His bundle recording has im-
proved the accuracy of the surface electrocardiogram in
predicting the site of block in patients with second degree
AV block (30,31). In patients with Mobitz type I block
(Wenckebach) and narrow QRS complexes. the block is
usually AV nodal (proximal to the His bundle), but also
may be intra-Hisian ("split" His bundle potentials). In pa-
tients with Mobitz type II block and narrow QRS complexes,
the block is almost always localized in the His bundle. In
patients with wide QRS complexes and second degree AV
block, the site of the block cannot be accurately diagnosed
from the surface electrocardiogram (Fig. 1). Type I block
may occur in the node, His bundle or bundle branches,
whereas type II block most likely represents the block in
the His-Purkinje system. In patients with advanced or com-
Figure 1. Intracardiac recordings in trifascicular disease. Surface leads I.
II, and V1 are displayed simultaneously with intracardiac recordings of the
high right atrium (HRA). His bundle electrogram (HBE) and right ven-
tricular apex (RVA). A = atrial deflection; H = His bundle deflection;
V = ventricular deflection. Time lines (T) are at 10 ms intervals. The
surface electrocardiogram demonstrates spontaneous second degree AV
block (Mobitz type I), with alternating bundle branch block. The first two
complexes exhibit right bundle branch block. left posterior fascicular block
and an HV interval of90 ms. The third complex has a normal QRS complex
and axis and shows further HV prolongation (125 ms). The fourth P wave
is blocked below the His bundle. The next complex exhibits right bundle
branch block, left anterior fascicular block and a prolonged HV interval.
plete AV block and narrow QRS complexes, the block is
in or proximal to the His bundle. Similarly, in patients with
wide QRS complexes, the block may be localized proximal
to, in or distal to the His bundle. In 1970, Rosen et al. (32)
reported a bizarre case of AV block with the electrocardio-
gram showing sudden changes in the PR interval and both
type I and type II second degree AV block. His bundle
recordings showed that the arrhythmia was a pseudo-AV
block secondary to nonpropagated His bundle depolarizations.
Bifascicular block: value of HV interval. The use-
fulness of His bundle recording in the presence of bifasci-
cular block has been a subject of much controversy. The
conduction system in human beings is trifascicular, con-
sisting of the right bundle branch and the two fascicles of
the left bundle branch (anterosuperior and posteroinferior)
(33). Patients with chronic bifascicular disease would appear
to be at risk for the development of complete heart block
(trifascicular). The HV interval in a patient with chronic
bifascicular block is a measure of conduction time through
the functioning fascicle. The value of the measurement of
the HV interval in predicting the development of trifasci-
cular block has been a topic of long-standing and heated
controversy. Some authors (34) have suggested that a long
HV interval is predictive of the subsequent development of
AV block. We and others (35,36) have not confirmed these
findings.
Our experience may be summarized as follows: 1) The
development of heart block in asymptomatic patients with
chronic bifascicular block is uncommon (approximately 2%
per year). The site of block varies and is trifascicular in
only 50% of the patients (37,38). 2) The small incidence
of progression to trifascicular block and the relatively high
prevalence rate of prolonged HV interval in patients with
bifascicular block precludes this measurement from being
useful in predicting the occurrence of heart block (35). 3)
There is a high cardiovascular mortality rate in patients with
bifascicular block and organic heart disease. This high rate
I
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is associated with the presence of increased age. advanced
heart disease and congestive heart failure (35). 4) Sudden
death in patients with bifascicular block and coronary artery
disease is frequently secondary to the development of ven-
tricular tachyarrhythmias rather than to the development of
heart block (36.39). We may conclude that measurement
of the HV interval is not helpful in the management of
asymptomatic patients with bifascicular block.
In symptomatic patients (syncope) with bifascicular block
electrophysiologic studies may be useful. However. in ad-
dition to measurement of the HV interval, these studies
should include the following: 1) complete testing of sinus
node function (40); 2) rapid atrial pacing as a means of
stressing the conduction system and demonstrating the pres-
ence of latent infra-His block (41) (second degree or ad-
vanced); 3) measurement of V-RVA (right ventricular apex)
conduction time and determination of the refractory periods
of the bundle branches and fascicles (42); 4) His bundle
pacing to demonstrate normalization of the QRS complex
and the presence of an intra-His lesion (43); 5) laboratory
administration of drugs that depress His-Purkinje conduction
(that is. ajmaline test [31J); and 6) ventricular stimulation
studies to test for the presence of ventricular tachyarrhyth-
mias. The diagnostic value of some of these tests is still
unproved or controversial. The limitation of electrophys-
iologic studies in the diagnosis of diseased His-Purkinje
conduction system is further exemplified by cases in which
such studies show totally normal findings in patients with
pathologically proved severe chronic conduction disease.
which may become clinically manifest as intermittent par-
oxysmal heart block (44).
Therapeutic Implications
Permanent pacing is indicated in all patients with sympto-
matic chronic heart block irrespective of the site of block
(30). In asymptomatic patients with chronic heart block,
demonstration of block distal to or within the His bundle is
an indication for permanent pacemaker insertion because of
an increased risk of Stokes-Adams attack (45,46). Asymp-
tomatic chronic AV nodal block appears to be relatively
benign and patients with this diagnosis may be followed
clinically without pacing (47). His bundle recording has
been less helpful in defining indications for pacing in pa-
tients with acute heart block related to acute myocardial
infarction. In these patients, the indications for pacing are
better defined by the site of infarction, the presence of in-
traventricular conduction defects (fascicular and bundle branch
block) and the electrocardiographic type of block (48).
Asymptomatic patients with bifascicular block need not be
submitted to electrophysiologic studies. In symptomatic pa-
tients with bifascicular block electrophysiologic studies may
be helpful in determining the need for permanent pacing or
antiarrhythmic drug therapy, or both.
Supraventricular Tachycardias
It is perhaps the knowledge of supraventricular tachycardia
that has benefited most from electrophysiologic studies. In
1967. Durrer et al. (49) demonstrated the role of premature
beats in initiating and terminating supraventricular tachy-
cardia in the Wolff-Parkinson-White syndrome. In 1970.
Bigger and Goldreyer (50) used coupled atrial stimulation
and His bundle recording to suggest that most paroxysmal
supraventricular tachycardias are reentrant, the AV node
being the probable site of reentry . We (51) reported in 1973
electrophysiologic evidence of dual AV nodal pathways.
providing a firm basis for the occurrence of AV nodal reen-
trance. Inaddition, paroxysmal supraventricular tachycardia
may be due to reentry in the atria or sinus node or may be
automatic in origin, arising from the atria or His bundle
(52).
AV Nodal Reentry
The most common mechanism of paroxysmal supraventric-
ular tachycardia in human beings is AV nodal reentrance
(52). In most patients with this tachycardia. it is possible
to demonstrate dissociation of the node into a fast and a
slow pathway. The determinants of reentrance that allow
induction of AV nodal reentrant paroxysmal supraventric-
ular tachycardia were studied by examining the properties
of fast and slow pathway conduction (53). Supraventricular
tachycardia could be induced in patients with dual atrio-
ventricular nodal pathways whose anterograde slow pathway
was capable of rapid repetitive anterograde conduction (as
assessed with atrial pacing) and whose retrograde fast path-
way was capable of repetitive retrograde conduction (as
assessed with ventricular pacing) (53). Thus, the occurrence
of paroxysmal supraventricular tachycardia in the presence
of dual AV nodal pathways was demonstrated to be a func-
tion of measurable anterograde and retrograde conduction
properties of the reentrant pathways (53). Pharmacologic
manipulation of the conduction properties (refractory period
and conduction time) of these pathways with atropine can
facilitate induction and maintenance of paroxysmal supra-
ventricular tachycardia. whereas depressing retrograde fast
pathway conduction with procainamide hydrochloride may
prevent induction of AV nodal reentrant tachycardia (54.55).
Retrograde block during tachycardia. Whether the
atrium is a necessary link (proximal common pathway) in
AV nodal reentrant tachycardias has been a subject of long-
standing controversy in electrophysiology (Fig. 2). Joseph-
son and Kastor (56) demonstrated capture and dissociation
of the atria during AV nodal reentrant tachycardia without
effect on the rate of the tachycardia. suggesting that the
atria were not a necessary link. Subsequent demonstration
of spontaneous retrograde block during AV nodal reentrant
tachycardia (ventriculoatrial block) that was reversible by
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Figure 2. Recordings demonstrating that the
right atrium and ventricle are not necessary
links for atrioventricular nodal reentrant tachy-
cardia. Surface leads I and V I are displayed
simultaneously with intracardiac recordings from
the high right atrium (HRA), coronary sinus
(CS), His bundle (HBE) and right ventricular
apex (RVA). S = stimulus artifact: A~ and V~
= premature paced beats. Time lines (T) are
at 10 ms intervals. Atrioventricular nodal reen-
trant tachycardia is present, with a cycle length
of 400 ms. In panel A, a single atrial extra-
stimulus (A2) is introduced with a coupling in-
terval of 300 ms capturing the right atrium.
However. the H-H and V-V intervals are un-
altered, suggesting that the right atrium is not
part of the reentrant circuit (56). Similarly. in
panel B, a right ventricular extrastimulus (V2)
with a coupling interval of 350 ms does not
change the H-H or A-A intervals. Despite ven-
tricular capture (V~) the reentrant circuit is
unaltered.
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atropine gave further credence to the previously mentioned
laboratory findings and also suggested that the site of block
was within the AV nodal tissue (57). Zipes et al. (58) dem-
onstrated that in rare cases of apparent junctional tachycar-
dia, although the surface electrocardiogram does not show
visible P waves, atrial activity can be recorded with catheters
placed in the area of the low septal right atrium or within
the coronary sinus. This observation suggests that the atria
itself may be dissociated, having only a rim of atrial tissue
that participates in the tachycardia circuit.
Reverse circuit tachycardia. Wu et al. (59) demon-
strated an unusual type of AV nodal reentry in which the
fast pathway is used in anterograde direction and the slow
pathway for retrograde conduction (reverse circuit). During
the usual type of AV nodal reentry, the P wave on the surface
electrocardiogram is usually within the QRS complex or
less frequently, it closely follows the QRS complexes (52).
In contrast, during the reverse circuit (unusual) AV nodal
reentry, the P wave precedes the QRS complex with a short
PR interval (52).
Preexcitation Syndromes
Wolff-Parkinson-White syndrome. This syndrome con-
tinues to be of great interest to the clinical electrophys-
iologist. In the syndrome, an anatomically proved structure
(Kent bundle) is responsible for the presence of arrhythmias
(60). Intracardiac and His bundle recordings, electrical stim-
ulation studies, intracardiac electrode mapping in the cath-
eterization laboratory, endocardial and epicardial mapping
in the operating room and results of surgical interventions
have confirmed the presence of the anomalous AV connec-
tion and demonstrated its role in the arrhythmias observed
clinically in patients with the Wolff-Parkinson-White syn-
drome (61).
His bundle recordings and atrial stimulation allow the
examination of the electrophysiologic properties of the nor-
mal and anomalous pathways (62). The P-delta interval is
a measure of anomalous pathway conduction time; the AH
interval reflects the normal pathway conduction time. The
QRS complex in the Wolff-Parkinson-White syndrome re-
sults from fusion during ventricular activation between the
normal and anomalous pathways. A short P-delta and a long
AH interval result in a wide and fully preexcited QRS com-
plex; conversely, a short AH and long P-delta interval give
rise to a more narrow and less abnormally conducted QRS
complex (partial preexcitation). The anomalous AV con-
nection may be located either in the free wall or within the
AV septum. The anomalous pathway location can be as-
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sessed with electrophysiologic techniques by mapping the
retrograde atrial activation sequence during paroxysmal su-
praventricular tachycardia with multiple catheters positioned
in the right atrium and coronary sinus (63), by stimulating
the atria at multiple sites and noting the site from which the
shortest stimulus to delta (P-delta) interval is obtained (64)
and by direct epicardial and endocardial mapping of the
heart during surgery (65).
The mechanism of the usual narrow QRS tachycardia in
the Woljf-Parkinson-White syndrome is characterized by an-
terograde conduction through the normal pathway (AV node-
His axis) and retrograde conduction by way of the anom-
alous AV connection (Fig. 3). Our laboratory investigated
the determinants of narrow QRS circus movement tachy-
cardia in 50 patients with preexcitation by studying patients
with and without inducible AV reentrant tachycardia (66).
Patients in whom paroxysmal supraventricular tachycardia
could not be induced had one or more of the following
findings: poor or absent retrograde anomalous pathway con-
duction; depressed anterograde AV nodal conduction and
prolonged atrial refractoriness. In a related study, we (67)
assessed the significance of the induction of narrow QRS
reciprocating tachycardia in patients with preexcitation. The
tachycardia was inducible in 100% of patients with docu-
Figure 3. Recordings showing bundle branch reentry initiating reentrant
supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Sur-
face leads I (I). aVF (F) and VI are displayed with simultaneous intra-
cardiac recordings from the high right atrium (HRA). His bundle (HBE)
and right ventricular apex (RVAj. During pacing of the right ventricular
apex at a cycle length of 600 ms (Sil. a single ventricular premature
stimulus (S2) is introduced with a coupling interval of 240 ms. producing
a V3 or bundle branch reentrant depolarization (95). The bundle branch
reentrant beat is preceded by an Hz potential with an HzV interval slightly
longer than the HV interval of the subsequent beats (95). The QRS con-
figuration of the bundle branch reentrant beat is similar to the that of the
paced beats (95). The bundle branch reentrant beat initiates an atrioven-
tricular reentrant supraventricular tachycardia (double reentry). The first
beat of the ensuing tachycardia has left bundle branch block aberrancy
with a ventriculoatrial (VA) interval of 180 ms: the subsequent narrow
QRS beats have a VA interval of 100 ms. This demonstrates the effect of
functional bundle branch block, which is ipsilateral to the accessory bypass
tract, on ventriculoatrial conduction time. During left bundle branch block
a longer ventriculoatrial conduction time is present. Thus, the anomalous
pathway in this case is in the left ventricle (72.75).
mented paroxysmal supraventricular tachycardia, 67% of
patients with documented atrial fibrillation, 36% of patients
with palpitation without documented arrhythmias and 8%
of asymptomatic patients with preexcitation. We (67) con-
cluded that laboratory induction of narrow QRS recipro-
cating tachycardia was a clinically significant event that was
directly related to the ability to have spontaneous parox-
ysmal supraventricular tachycardia. The ability to induce
reciprocating tachycardia in a high percent of patients with
documented atrial fibrillation was consistent with the sug-
gestion that the spontaneous degeneration of paroxysmal
supraventricular tachycardia into atrial fibrillation may be a
common cause of atrial fibrillation in such patients (68,69).
Less frequently, wide QRS tachycardias may be observed
in the Woljf-Parkinson-White syndrome (69). These tachy-
cardias may be due to the following mechanisms: I) func-
tional bundle branch block during the usual AV reentrance;
2) atrial reentry or atrial flutter with I: I anterograde con-
duction over the anomalous pathway: 3) AV nodal reentry
with anterograde anomalous pathway conduction; 4) the
reverse form of reciprocating tachycardia (antidromic) using
the anomalous pathway for anterograde conduction and the
normal pathway for retrograde conduction; and 5) recip-
rocating tachycardia utilizing two or more anomalous path-
ways (concealed, or manifest, or both).
Atrial fibrillation is a major life-threatening arrhythmia
in patients with the Woljf-Parkinson-White syndrome. Klein
et al. (70) studied patients who had suffered from sponta-
neous ventricular fibrillation. They noted that ventricular
fibrillation was usually caused by atrial fibrillation with rapid
ventricular response due to a short anomalous pathway re-
fractory period. Sellers et al. (71) emphasized the role of digi-
talis in the development of ventricular fibrillation during ep-
isodes of atrial fibrillation in patients with preexcitation and
short refractoriness of an anomalous pathway. Digitalis
appeared to increase ventricular vulnerability to ventricular fi-
brillation. Induction of atrial fibrillation by pacing in the cath-
eterization laboratory in patients with the Wolff-Parkinson-
White syndrome has been helpful in identifying patients at
high risk for the development of ventricular fibrillation and
also in evaluating antiarrhythmic drug responses (20).
Concealed anomalous pathway tachycardia. In some
patients with paroxysmal supraventricular tachycardia, the
mechanism of tachycardia is related to the presence of a
concealed extranodal anomalous pathway that is capable
only of retrograde conduction (72). The electrocardiogram
during sinus rhythm in these patients does not reveal preex-
citation. During circus movement tachycardia, the AV node-
His axis is utilized for anterograde conduction and the con-
cealed bypass tract is used for retrograde conduction. There
have been controversies regarding the differentiation be-
tween right septal concealed anomalous connection and ret-
rograde conduction in rapid intranodal pathways.
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The electrophysiologic diagnosis of the concealed anom -
alous pathway is based on the following findings : I) fixed
ventriculoatrialconduction and atrio-His dissociationduring
ventricular pacing (73); 2) abnormal retrograde atrial acti-
vation sequence during tachycardia and ventricular pacing
(63): 3) reset of the atria with ventricular extrastimuli during
tachycardia when the His bundle is refractory (74): and 4)
increase in ventriculoatrial conduction during tachycardia
with functional bundle branch block ipsilateral to the con-
cealed bypass tract (Fig. 3) (72,75).
Atrioventricular nodal bypass tract. The syndrome
of short PR interval, normal QRS complex and paroxysmal
supraventricular tachycardia (Lown-Ganong-Levine syn-
drome) has also generated much interest in clinical electro-
physiology (76). The exact anatomic basis for this syndrome
is still not completely understood. There are several possible
explanations. including partial atrionodal bypass tract (James
fibers). atrio-His connection and rapidly conducting pref-
erential intranodal fibers. Electrophysiologic studies have
demonstrated that the AV nodal conduction time is abbre-
viated (AH < 60 rns) , the His-Purkinje conduction time may
be normal or short (HV < 30 rns) and the intraatrial con-
duction time (PA) is normal (77). In response to atrial pacing
enhanced AV nodal conduction can be demonstrated (78).
This enhanced conduction results in faster tachycardia rates
and also more rapid ventricular response during atrial
fibrill ation.
The mechanism of paroxysmal supraventricular tachy-
cardia in these patients is variable . Some have intranodal
reentry with dual AV nodal pathways; others demonstrate
the presence of an additional concealed anomalous AV con-
nection (78). Enhanced AV nodal conduction can result in
a short coupling interval of premature atrial beats or rapid
ventricular response during atrial fibrillation resulting in
ventricular tachycardia or fibrillation. or both (79).
Nodoventricular and fasciculoventricular anomalous
pathway. Although the Mahaim fibers have been confirmed
anatomically, their role in the genesis of cardiac arrhythmias
remains unclear (80). The electrophysiologic manifestation
of the Mahaim fibers is dependent on the site of their origin
within the AV node-His axis (80). Fibers that originate at
the level of the node are called nodoventricular fibers and
those that originate in the His bundle and bundle branches
are termed fasciculoventricular fibers. The PR interval may
be short or normal depending on the insertion of these fibers
relative to the area of AV nodal conduction delay. The
degree of preexcitation (fusion) is dependent on the relative
conduction times of the AV node-His axis and the anom-
alous pathway. The higher their takeoff (proximal nodo-
ventricular fibers), the shorter the PR interval. The fasci-
culoventricular fibers are associated with a normal PR interval
and delta wave. His bundle extrasystoles or His bundle
pacing normalizes the QRS configuration in a nodoventri-
cular connection, whereas the anomalous QRS complex
configuration should persist in a fasciculoventricular con-
nection, unless the extrasystole arises below the insertion
of these fibers. It is interesting to note that the electrocar-
diographic pattern of all reported nodoventricular fibers
demonstrated a left bundle branch block configuration (80l.
The mechanism of arrhythmias in patients with nodo-
venticular bypass tracts may be related to a circus movement
Tachycardia that incorporates the anomalous connection in
an anterograde (wide QRS tachycardia) or retrograde (nar-
row QRS tachycardia) direction (80). The nodoventricular
fibers may also be used for anterograde conduction during
atrial reentry, AV nodal reentry or atrial fibrillation and
flutter. The role of fasciculoventricular fibers in the genesis
of cardiac arrhythmias is unclear (80). The combination of
enhanced AV nodal conduction and fasciculoventricularby-
pass tract can mimic the Wolff-Parkinson-White syndrome
and result in rapid ventricular response during atrial fibril-
lation (80).
New pathways with AV nodal conduction proper-
ties. Recent studies have demonstrated the presence of
anomalous AV connections with decremental conduction
properties (81-83). In some of these studies. theconnections
were functioning in ventriculoatrial direction forming part
of a reciprocating tachycardia (81.82), In other instances.
the anomalous pathway was conducting in an anterograde
direction resembling a nodoventricular bypass tract (83).
Some of these pathways have been demonstrated with epi-
cardial mapping followed by surgical ablation (81,83 ). The
paroxysmal supraventricular tachycardia that uses the anom-
alous connection in retrograde direction tends to be per-
sistent because the slow retrograde conduction allows for
stable circus movement (81,82), An anomalous sequence
of atrial or ventricular depolarization may be observed de-
pending on whether the anomalous pathway is used in a
retrograde or an anterograde direction. These pathways have
unusual pharmacologic responses, and conduction may be
depressed by drugs that slow AV nodal conduction (82) . It
is possible that these anomalous pathways represent acces-
sory AV nodes that have been demonstrated to occur in
some congenital heart defects (84).
Miscellaneous Reentrant Supraventricular
Tachycardias
Sinus or atrial reentrant tachycardias account for approxi-
mately 10% of cases of clinical paroxysmal supraventricular
tachycardia (52). These can be initiated and terminated by
appropriately timed atrial extrastimuli. Induction of tachy-
cardia is unrelated to achievement of critical AV nodal de-
lay, and the presence of AV conduction is not necessary
for induction or continuation of the tachycardia. Specific
anatomic pathways that participate in the reentrant circuit
have not been demonstrated in human subjects. Organic
heart disease can be diagnosed in the great majority of these
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patients (52) . The diagnosis of sinus node reentry is made
when the atrial activation sequence and P wave configuration
during tachycardia resemble those of sinus P waves. and
atrial reentry is diagnosed when these characteristics differ
from tho se of the sinus P wave (85). Coumel (86) described
an interesting type of reentrant paro xysmal supraventricular
tachycardia that was characterized by an incessant nature .
Initiation of the ince ssant form of paro xysmal supraven-
tricular tachycardia is not dependent on a crit ical conduction
delay , but is determined by critical rates and coupling in-
tervals of the initiating beats (86). It is postulated that these
are reentrant tachycardias and that induction is dependent
on the occurrence of a concealed block in one of the par-
ticipating pathways in the reentrant circuit. The blocked
pathway is subsequently utilized for retrograde conduction.
The nature of the reentrant pathway varies; in some tachy-
cardias the reentry is intranodal and in others an extranodal
pathway with slow retrograde conduction is used (81,82.86).
During paroxysmal supraventricular tachycardia . the P waves
precede the QRS complexes and resemble an atrial reentrant
tachycard ia .
Progress in the study of paroxysmal supraventricular
tachycardia has been slowest in the area ofautomatic tachy-
cardias (87) . It is an infrequent form (4%) of parox ysmal
supraventricular tach ycardia and the diagnosis is made by
exclusion of reentrance (52).
Therapeutic Implications
Perhaps the greatest progress in the therapy ofarrhythmia s
has been achieved in the management of supraventricular
tachyarrhythmias. This progress has been due to: I) de-
velopment of a new electrophysiologic technique, the "chronic
elect rophysiologic study," which provides a rational basi s
for delineating effective antiarrhythmic therapy (88); 2) de-
velopment of specially designed anti tachycardia pacemakers
(89); and 3) development of intraoperative mapping tech-
niques that allow identification of the locati on of anomalous
AV connections and surgical ablation of these structures
(90). Both the drug and pacemaker therap ies are palliative ,
the former preventing induction of tachycardia and the latter
terminating episodes of sustained tachycardi a. In the ex-
perience of Gallagher and Sealy and their co-workers (61.90)
the surgical interruption has been curative in most patients .
Chronic electrophys iologic studies involve the laboratory
replicati on of the tachyarrhvthmias with programmed pac-
ing techniqu es and the systematic testing of antiarrhythmic
drugs (88 ). Those drugs that prevent induction of sustained
tachycardia in the laboratory have proved effective in pre-
vent ing the occurrence of spontaneous attacks during long-
term follow -up periods (88). Surgical techniques have also
evolved significantly durin g the last few years. The use of
cryoablation has added a more precise and less destructive
method for ablation of the anomalou s AV connections or
His bundle (61.90) . We believe that most supraventricular
tachycardias can be managed med icall y (with drugs or a
pacemaker or both). However. surgical therapy is recom-
mended for patients with intractable arrh ythmias and es-
peciall y for those who have pree xcitation syndrome and
atrial fibrillation with rapid ventricular respon se .
Ventricular Tachycardias
One of the most significant contributions of clini cal elec-
trophysiolog y during the past decade has been in the un-
derstanding and management of ventricular tachycardia (91),
In 1972. Wellens et al, (92) were the first to describe the
use of programmed stimulation techniques in the evaluation
of ventricular tachycardia . Postulatin g that reentry might be
the responsible mechanism for ventricular tachycardia, they
were able to initiate and terminate the tachycardia with
single ventricular extrastimul i (92) . The ability to induce
the tach ycardia was found to be depend ent on the pacing
rate and site of stimulation (93 .94) . Thus, the electrophys-
iolo gic requirements that govern the ability to initiate or
term inate the arrh ythmi a were thought to be very similar to
those that had been studied extensively in supraventricular
tachycardi a. In contrast to supraventricular tachycardia , the
exac t anatomic location of the reentr ant pathways and the
determinant s of reentrance in ventricular tachycardia have
not been defined. A clinical model of macroreentry involv-
ing the His bundle and bundle branches was described by
Akht ar et al. (95) in 1974 . The bundle branch reentrant beat
was termed the " V3 " phenomenon or bundle branch reen-
try . because it followed the introduction of a critically timed
paced ventricular premature beat (V2) (Fig. 3). However,
bundle branch reentry is not involved in the mechanism of
most ventricular tachycardias . Because the pathophysiology
of ventricular tachycardia is not completely understood, most
cla ssifications of these rhythms are arbitrary. We shall cla s-
sify them in the following gro ups: I) chronic recurrent sus-
tained ventricular tach ycardia; 2) nonsustained ventri cular
tachycard ia; 3) ventricular tachycard ia and fibrillation re-
lated to sudden death; and 4) miscellaneous reentrant ven-
tricul ar tach ycardia .
Chronic recurrent sustained ventricular tachycar-
dia. Joseph son and co-workers at the University of Penn-
sylvania extensi vely studied the pathoph ysiology of ven-
tricul ar tachycardia. Thei r studies sugges t that recurrent
sustained ventricular tach ycardia associated with chronic
coronary artery disease is reentrant , and is located in a
relatively small area of the ventricles involving the endo-
card ium (microreentry ). These conclusions are based on the
following observations: 1) Ventricular tach ycardia can be
initiated and terminated with programmed electrical stim-
ulation (92-94 . 96). The induction of tachycardia with pro-
grammed electrical stimulat ion co incides with the occur-
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Figure 4. Endocardial activation times during sustained ventricular tachy-
cardia. Surface leads 1. II. and VI are recorded simultaneously with an
intracardiac reference electrogram (right ventricular apex, RVA) and mul-
tiple recordings from the exploring electrode catheter in the left ventricle.
The mapping sites correspond to the schema reported by Josephson et al.
(99). Sites II and 12 are in the anterior wall, site 9 in the anterolateral
wall. site 3 in the midseptum, site I in the left ventricular apex and site
2 in the low septum. The earliest sites of endocardial activation (9-11)
demonstrate early fractionated electrical activity. Intraoperative mapping
confirmed the location of the earliest site of activation in the low antero-
lateral endocardial surface, corresponding to a densely fibrotic calcified
scar and old thrombus. Endocardial excision was curative.
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(106). Similar findings were reported by Josephson et al.
(107), who noted an inducibility rate of 63% in patients
with ventricular tachyarrhythmias documented at the time
of cardiac arrest. The large incidence of induced ventricular
tachycardia rather than ventricular fibrillation as the initi-
ating mechanism of the laboratory-provoked cardiac arrest
was of particular interest (106,107). It appears that ven-
tricular tachycardia associated with hemodynamic collapse
(hypotensive ventricular tachycardia) may spontaneously
degenerate into ventricular fibrillation. Thus, hypotensive
ventricular tachycardia is probably the most frequent pre-
cipitating cause of ventricular fibrillation and sudden death
in these patients. Ventricular fibrillation occurs infrequently
during programmed ventricular stimulation and usually in
response to double ventricular extrastimuli (108), Induction
of ventricular fibrillation by these pacing techniques iden-
tifies patients with previous clinical episodes of ventricular
fibrillation or those at high risk for future occurrence of the
arrhythmia (100,108).
renee of marked conduction delay, as evidenced by fragmented
or continuous electrical activity of the ventricular muscle
(97). 2) Capture of a large portion of the ventricle, including
the His bundle and bundle branches, can occur during the
tachycardia without affecting the reentrant circuit (98,99).
The technical aspects of induction and termination of
tachycardia regarding the site of stimulation and the number
of extrastimuli required have been studied at length (91,100).
Chronic sustained ventricular tachycardia can be induced
with programmed ventricular stimulation in 90% of patients
(100). Most patients (63%) require double extrastimuli from
the right ventricle for induction of the tachycardia (100).
Left ventricular stimulation is required in only about 10%
of patients (100). The clinical significance of induction of
ventricular tachycardia has also been assessed; sustained
ventricular tachycardia is inducible in 91% of patients with
documented spontaneous sustained tachycardia and in 0.3%
of patients who have no clinical evidence for ventricular
tachycardia (100). The site at which the ventricular tachy-
cardia originates can be assessed with electrophysiologic
techniques, such as endocardial mapping and pace mapping
in the catheterization laboratory and with epicardial and
endocardial mapping in the operating room (Fig. 4) (99,100-
102). These studies have also demonstrated the limited use-
fulness of the surface electrocardiogram in locating the site
of origin of ventricular tachycardia (103).
Nonsustained ventricular tachycardia. This form of
ventricular tachycardia has been more resistant to electro-
physiologic analysis. Nonsustained ventricular tachycardia,
particularly in the absence of ischemic heart disease, fre-
quently cannot be reproduced in the catheterization labo-
ratory (94,100). The difficulties in reproducing the arrhyth-
mias limit the definition of specific mechanism and drug
responses. Nonsustained ventricular tachycardia is consid-
ered an independent risk factor for sudden death in patients
with coronary artery disease after an acute myocardial in-
farction (104). In contrast to the poor prognosis associated
with nonsustained ventricular tachycardia in patients after
a myocardial infarction, we described a group of young
patients with nonsustained ventricular tachycardia and ex-
cellent prognosis (105). These patients were mostly women
without diagnosable organic heart disease whose tachycardia
had a left bundle branch block configuration (105). Further
work is required to improve our understanding of the elec-
trophysiology of this type of arrhythmia.
Ventricular tachycardia and fibrillation related to
sudden death. Sudden cardiac death in patients with cor-
onary artery disease is usually secondary to ventricular
tachycardia or fibrillation. Ruskin et al. (106) studied 31
survivors of cardiac arrest who had not had an acute myo-
cardial infarction. All patients had documented ventricular
tachycardia or ventricular fibrillation at the time of resus-
citation. The clinical arrhythmia was successfully repro-
duced in the catheterization laboratory in 81% of the patients
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Miscellaneous ventricular tachycardias. Electro-
physiologic studies have not aided the management of ven-
tricular tachycardia in the immediate post-myocardial in-
farction period (93 ,109) . Some studies have suggested that
the " torsade de pointe s" type of ventricular tachycardia is
reentrant and can be induced with electrical stimulation in
patients with and without a long QT interval (110, III ).
Electrophysiologic studies have been most helpful in the
study of patients with arrhythmogenic right ventricular dys-
plasia (112 ). In this disease , first described by Fontaine et
al. (l12) , certa in parts of the right ventricular myocardium
demon strate fatty infiltration and aneurysmal dilation; these
pathologic changes predispose to the occurrence of life-
threatening ventricular arrhythmi as. The significance of un-
derlying heart disease other than ischemic heart disease (mi-
tral valve prolapse, cardiomyopathies, infiltrative disease,
tumors) needs further evaluation. The possibility that trig-
gered automaticity might be a mechanism of ventricular
tachycardia in human beings was recently raised by Zipes
et al. (113 ).
Therapeutic Implications
As in the management of supraventricular tachycardia, ma-
jor progre ss has been made in the therapy of ventricular
tachyarrhythmias. Chronic electroph ysiologic studies, anti-
tachycardia pacemakers and new operative techniques are
responsible for these major improvements (9 1).
Electrophysiologic drug testing. The capability of ini-
tiating sustained ventricular tachycardia with only a small
risk led to the use of these techniques to select anti-
arrhythmic medications ( 114- 116) . Electrophysiologic drug
testing has provided an objective basis for choosing proper
therapy because clinical episodes of ventricular tachycardia
or fibrillation appear unpredictably and may be lethal and
because spontaneous ventricular ectopic activity between
episode s does not appear to be a useful guide for judging
drug efficacy (91,117). A major exception to this premise
is the drug amiodarone. Electrophysiologic testing with this
particular drug remain s contro versial because the incidence
of clinical recurrence does not correlate with inducibility of
the tachycardia (118).
Antitachycardia pacemakers. With the remarkable ad-
vances in pacemaker technology, electrophysiologic testing
became an important tool in assessing patients who will
benefit from this new form of therap y (119 ). Patients who
have a relatively slow rate of spontaneous tachycardia and
in whom pacing techniques have been shown in the labo-
ratory to terminate the tachycard ia appear to be the optimal
candidates for this treatment (119) . However , as has been
well documented, pacing techniques (in particular rapid pac-
ing) may actually accelerate the tachycardia and cause
hemodynamic collapse (119). A recent significant advance
has been the the development of an implantable automatic
defibrillator by Mirowski et al. (120 ). The implantable de-
fibrillator may be very useful for patients who are not op-
timal surgical candidates and whose tachycardias cannot be
controlled with antiarrhythmic agents.
Surgical procedures. Surgical therapy for treatment of
ventricular tachycardia has been attempted, including cor-
onary artery bypass grafting and aneurysmectom y with or
without revascularization. The results reveal a high mor-
tality rate and unpredictable resolution of the arrhythmias
(121). Because ventricular tachycardia in patients with chronic
ischemic heart disease is most likely caused by a relatively
small protected reentrant circuit in the border of the ischemic
or necrotic tissue, several surgical procedures were devel-
oped in an attempt to interrupt this circuit. Fontaine et al.
(112) described a transmural ventriculotomy using epicar-
dial mapping techniques. The incision incorporated the area
demonstrating late activation potentials seen during sinus
rhythm and the site of earlie st epicardial activation during
ventricular tachycardia. This technique met with limited
success. Studies from the University of Pennsylvania sub-
sequently demonstrated that the earliest electrical activity
initiates from the endocardium and most frequently within
the border zone of infarcted tissue (9 1,99, 101,122). On
the basis of these findings a new surgical technique , the
endocardial excision, was developed (122) which has an
operative mortality rate of approx imately 10%. The major
limitations of this surgical procedure are that the tachycar-
dias originating from the papillary muscle or areas contig-
uous to valvular anuli must frequentl y be treated by resection
of the area in addition to valve replacement, which signif-
icantly increases mortalit y. Second, many patients become
hemodynamically unstable during ventricular tachycardi a,
and under these circumstances it is often difficult to obtain
complete activation data, especially in those whose tachy-
cardia has several configurations.
Another operative procedu re that has been successfully
used is the encircling endocardial ventriculotomy . Devel-
oped by Guiraudon et al. (123), this technique involves the
direct inspection of the extent of the scar formation . A
transmural ventriculotomy perpendi cular to the wall is per-
formed along the margin of the endocardial scar that phys-
ically separates normal tissue from the infarcted area . This
procedure has the advantage of not requiring arrhythmia
induction at the time of surgery and, furthermore, it pre-
serves the papillary muscle and valvular integrity. Unfor-
tunately, the procedure interrupt s myocardial blood flow to
relatively large region s of the heart , causing deterioration
of myocard ial function within the area of the ventricul-
otomy. Consequently, the operative mortality rate is higher
with this procedure, largely as a result of impaired left
ventricular hemodynamics .
Future requirements. Although great advance s have
been made in the recogn ition and management of patients
with malignant ventricular arrhythmias during the past dec-
ade , this area of clinical electrophysiology is still in its early
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stages. Programmed stimulation techniques have provided
some answers but have also generated many new questions.
The role of electrophysiologic studies in patients with non-
sustained ventricular tachycardia and in cases of unex-
plained syncope has yet to be resolved. The prognostic
significance of ventricular arrhythmias induced in patients
who have not clinically experienced the arrhythmia is also
problematic. Greene et al. (124) suggested that a repetitive
ventricular response (two or more ventricular premature beats
produced by a single ventricular extrastimulus) in patients
after a myocardial infarction identifies those at high risk for
life-threatening ventricular arrhythmias and death. How-
ever, this finding has not been confirmed by other investi-
gators (125). Among patients who are considered good sur-
gical candidates, further technologic advances are needed
to localize the origin of the tachycardia with greater pre-
cision and patient safety. Better surgical techniques are also
needed that will ablate the tachycardia with the least possible
mortality and recurrence of arrhythmia.
We gratefully acknowledge Lillian Linares' secretarial assistance in the
preparation of this manuscript.
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